Maravai Lifesciences Holdings (MRVI) Net Margin (2020 - 2025)
Historic Net Margin for Maravai Lifesciences Holdings (MRVI) over the last 6 years, with Q3 2025 value amounting to 108.23%.
- Maravai Lifesciences Holdings' Net Margin rose 1416100.0% to 108.23% in Q3 2025 from the same period last year, while for Sep 2025 it was 111.11%, marking a year-over-year increase of 57900.0%. This contributed to the annual value of 100.17% for FY2024, which is 522800.0% down from last year.
- Maravai Lifesciences Holdings' Net Margin amounted to 108.23% in Q3 2025, which was up 1416100.0% from 147.34% recorded in Q2 2025.
- In the past 5 years, Maravai Lifesciences Holdings' Net Margin registered a high of 64.57% during Q2 2022, and its lowest value of 249.84% during Q3 2024.
- For the 5-year period, Maravai Lifesciences Holdings' Net Margin averaged around 26.27%, with its median value being 17.33% (2023).
- Per our database at Business Quant, Maravai Lifesciences Holdings' Net Margin crashed by -2272600bps in 2024 and then surged by 1416100bps in 2025.
- Over the past 5 years, Maravai Lifesciences Holdings' Net Margin (Quarter) stood at 55.64% in 2021, then decreased by -23bps to 42.71% in 2022, then crashed by -447bps to 148.34% in 2023, then surged by 45bps to 81.45% in 2024, then tumbled by -33bps to 108.23% in 2025.
- Its Net Margin stands at 108.23% for Q3 2025, versus 147.34% for Q2 2025 and 112.81% for Q1 2025.